NEWS INFORMATION

The News Window

Home page

News dynamics 

Company News Industry News

Voice of the Party 

Party building work Trade Union Activities

22-03

Chengda Bio: Fifteen-valent HPV vaccine clinical trial approved.

22-03

Announcement of Liaoning Provincial Drug Administration on Entrusted Distribution and Storage of Vaccine Production Enterprises (No. 2 of 2022)

22-03

Announcement of Liaoning Provincial Drug Administration on Entrusted Distribution and Storage of Vaccine Production Enterprises (No. 26 of 2021)

22-03

Announcement of Liaoning Provincial Drug Administration on Entrusted Distribution and Storage of Vaccine Production Enterprises (No.21 of 2021)

21-11

Company basic information

20-12

Announcement of Liaoning Provincial Drug Administration on Entrusted Distribution and Storage of Vaccine Production Enterprises (No. 8 of 2020)

20-12

Drug Quality and Safety Commitment

20-11

The 11th meeting of the Executive Committee of the Pharmacopoeia Committee was held in Beijing to consider and approve the draft of the 2020 edition of the Chinese Pharmacopoeia.

20-04

Chengda Bio Donates One Million Yuan to Help Prevent and Control Epidemic

20-03

Draft Biosecurity Law submitted to NPC Standing Committee for deliberation for the first time

< 1 2 3 4 5 6 7 > proceed page

Telephone

024-23789706

Marketing Center

010-68785856

International Trade

024-83787033

Medical Consultation

400-101-1359 （weekday）

Address

No.1, XinFang Street, Hunnan New District, Shenyang City

辽ICP备15013481号-1

123456789

12456789